Paul Hsieh, MD of Freedom and Individual Rights in Medicine writes:
The Food and Drug Administration (FDA) is on the verge of taking the highly unusual step of “decertifying” the cancer drug Avastin that it had previously approved. In addition to sparking concerns that this is another step towards medical rationing, ...
So says a press release from the Independent Institute:
Oakland, CA, Feb. 10, 2010—The Food and Drug Administration (FDA) has requested a $4.03 billion budget for FY2011, a 23 percent increase over last year. Prompted by the FDA’s vast reach and alarming budget, a new report delves into the organization’s history, ...
From a new Cato Institute policy analysis, Bending the Productivity Curve: Why America Leads the World in Medical Innovation:
The health care issues commonly considered most important today — controlling costs and covering the uninsured — arguably should be regarded as secondary to innovation, inasmuch as a medical treatment must first ...
David R. Henderson and Charles L. Hooper have an excellent column in Forbes. An excerpt:
Do you need a government agency to tell you which TV has a vivid picture? Do you need a government agency to tell you which car is reliable? How about which coffee tastes yummy or which ...
From the Denver Post:
Gov. Bill Ritter suffered a quiet loss Tuesday when the Senate gave initial approval to a bill that would repeal a program created by the first bill he signed into law.
The Colorado Cares Rx Program was created in 2007 as a way to help low-income Coloradans access ...
Charles L. Hooper and David R. Henderson in Forbes:
Since Barack Obama was elected, there has been much hopeful talk about addressing this country's health care problems. Unfortunately, some of the ideas discussed have been bad ones and, therefore, will have predictably bad consequences.
Consider the FDA's recent appointment of Dr. Sidney ...
Daniel Klein, economist at George Mason University, offers his answer to the Davos Question, saying that drugs approved in Canada, Britain, and other places gain automatic approval in the United States. The drug-approving agencies of recognized countries would become more responsive to the needs of humanity. The proposal is called ...
He would, suggests Charles Hooper at Forbes.com. Some selections:
Say a biotech company is developing a new drug for breast cancer. My consulting firm, Objective Insights, looks at the financial value of the project. If the expected value--probability-adjusted value--of the project is negative, we suggest discontinuing development. Often, millions of dollars ...
Sally Pipes from the Pacific Research Institute has published this new book through . Here's the Table of Contents:
Foreword by Steve Forbes
Myth One: Government Health Care Is More Efficient
Myth Two: We're Spending Too Much on Health Care
Myth Three: Forty-Six Million Americans Can't Get Health Care
Myth Four: High Drug Prices Drive ...
Fox News, July 23:
The Seattle Mariners are declaring two sections of Safeco Field no-peanut zones for a couple of games this summer.
The AL club announced the move Wednesday to make the ballpark safer for children and grown-up fans with peanut allergies.
This could be a good business decision, but let's hope ...
